ID

18532

Descripción

Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00098085

Link

https://clinicaltrials.gov/show/NCT00098085

Palabras clave

  1. 9/11/16 9/11/16 -
Subido en

9 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-Small-Cell Lung Carcinoma NCT00098085

Eligibility Non-Small-Cell Lung Carcinoma NCT00098085

Criteria
Descripción

Criteria

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
suspected non-small cell lung cancer, stage ib, stage ii, or stage iiia
Descripción

Non-Small Cell Lung Carcinoma Suspected | TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0332147
UMLS CUI [2]
C3258246
tumor size > 3x3 cm or equivalent to a 9 cm² lesion
Descripción

Tumor size | Lesion size Equivalent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0475440
UMLS CUI [2,1]
C0449453
UMLS CUI [2,2]
C0205163
scheduled surgery with curative intent
Descripción

Curative Surgery Planned

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1511562
UMLS CUI [1,2]
C1301732
at least 18 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
must not be pregnant or breast feeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
agree to not receive any other investigative agent at any time while enrolled in this study
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment for non-small cell lung cancer
Descripción

Prior Therapy Non-Small Cell Lung Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0007131
clinical signs or symptoms of brain metastases
Descripción

Metastatic malignant neoplasm to brain Sign or Symptom Clinical

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C3540840
UMLS CUI [1,3]
C0205210
history of immune suppression or autoimmune disorder
Descripción

Immunosuppression | Autoimmune Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4048329
UMLS CUI [2]
C0004364
severe active infection or other serious medical illness, that in the opinion of the principal investigator, would prevent study completion
Descripción

Communicable Disease Severe Preventing Clinical Trial Completion | Illness Serious Preventing Clinical Trial Completion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C1292733
UMLS CUI [1,4]
C0008976
UMLS CUI [1,5]
C0205197
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C1292733
UMLS CUI [2,4]
C0008976
UMLS CUI [2,5]
C0205197
other malignancies in the past 5 years, except adequately treated in situ cervix carcinoma or non-melanoma skin cancer
Descripción

Malignant Neoplasms | Carcinoma in situ of uterine cervix Treated | Skin carcinoma Treated

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0851140
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C0699893
UMLS CUI [3,2]
C1522326

Similar models

Eligibility Non-Small-Cell Lung Carcinoma NCT00098085

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Suspected | TNM clinical staging
Item
suspected non-small cell lung cancer, stage ib, stage ii, or stage iiia
boolean
C0007131 (UMLS CUI [1,1])
C0332147 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
Tumor size | Lesion size Equivalent
Item
tumor size > 3x3 cm or equivalent to a 9 cm² lesion
boolean
C0475440 (UMLS CUI [1])
C0449453 (UMLS CUI [2,1])
C0205163 (UMLS CUI [2,2])
Curative Surgery Planned
Item
scheduled surgery with curative intent
boolean
C1511562 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
must not be pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
agree to not receive any other investigative agent at any time while enrolled in this study
boolean
C0013230 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Therapy Non-Small Cell Lung Carcinoma
Item
previous treatment for non-small cell lung cancer
boolean
C1514463 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Sign or Symptom Clinical
Item
clinical signs or symptoms of brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C3540840 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Immunosuppression | Autoimmune Disease
Item
history of immune suppression or autoimmune disorder
boolean
C4048329 (UMLS CUI [1])
C0004364 (UMLS CUI [2])
Communicable Disease Severe Preventing Clinical Trial Completion | Illness Serious Preventing Clinical Trial Completion
Item
severe active infection or other serious medical illness, that in the opinion of the principal investigator, would prevent study completion
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0205197 (UMLS CUI [1,5])
C0221423 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1292733 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0205197 (UMLS CUI [2,5])
Malignant Neoplasms | Carcinoma in situ of uterine cervix Treated | Skin carcinoma Treated
Item
other malignancies in the past 5 years, except adequately treated in situ cervix carcinoma or non-melanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
C0851140 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0699893 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial